MJ Biotech Offers Covid-19 FDA Approved Nasopharyngeal Specimen Collection Swabs RT-PCR COVID Test Kit

Rhea-AI Summary

MJ Biotech, Inc. (OTC PINK:MJTV) has added FDA-approved nasopharyngeal specimen collection swabs for RT-PCR COVID tests to its product line, enhancing its offering alongside existing COVID-19 IgG/IgM Antibody Rapid Test Kits. This expansion follows requests from Invest Africa Global, LLC (IAG), which represents MJ Biotech in Africa and has identified several business opportunities. The newly introduced RT-PCR test provides flexibility for active COVID-19 testing. Samples have already been shipped, and logistics for order fulfillment are being established.

Positive

• Introduction of FDA-approved nasopharyngeal swabs offers a competitive edge.
• Collaboration with Invest Africa Global enhances market reach in Africa.
• Flexibility in testing options with both RT-PCR and antibody tests.
• Initial shipments indicate strong demand and operational readiness.

Negative

• None.

CHEYENNE, WY / ACCESSWIRE / February 24, 2021 / MJ Biotech, Inc. (OTC PINK:MJTV), is pleased to report that Sterile and individually wrapped FDA approved nasopharyngeal (nasal) specimen collection swabs for the RT-PCR COVID test was added to the COVID -19 product line. This Covid-19 test (inclusive of the swabs to the RT-PCR test) is in addition to the Covid-19 IgG/IgM Antibody Rapid Test Kits already being offered by MJ Biotech, Inc. Sales representative, Invest Africa Global, LLC (IAG) asked MJTV to add this to the product offering at the request of IAG's customers.

MJ Biotech Shipped out Samples of this RT-PCR Covid-19 Test last week to IAG customers. The RT-PCR Covid-19 Test and Covid-19 IgG/IgM Antibody Test now gives the IAG buyers the flexibility, to either test individuals for the active Covid-19 or the Covid-19 Antibodies.

The logistics of the first order from delivery to payment are currently being worked on. After the first transaction is completed, a seamless process will be in place to handle subsequent new and repeating transactions.

IAG is representing MJ Biotech, Inc. in multiple jurisdictions on the African Continent. They have secured several potential business opportunities for the Covid-19 Antibody Test Kit and now the Nasopharyngeal specimen collection swabs and RT-PCR COVID test.

A deeper and enhanced Scientific viewpoint of the RT-PCR Covid-19 Test Product:

The Coronavirus (Covid-19) specimen collection swabs are suitable for collecting both nasopharyngeal (NP) or oropharyngeal (OP) Covid-19 contaminated secretions. The testing swab consist of a flocked nylon fiber head (3mm x 16 mm), with a polypropylene handle that is 15.1 cm. The polypropylene handle has a molded break point at 8.2 cm, which easily fractures, for simple transport and placement into sterilized transport media.

The Covid-19 collection swabs are transported in a sterilized collection tube, secured with a twist on cap. The collected Covid-19 specimen test is then placed in a E -beam irradiation packaging. These strict and sterile conditions would prevent DNase, RNase, endotoxins, or cell inhibitors, potentially contaminating the Covid-19 specimen test sample. The Covid-19 collection swabs have a extraordinary water absorption capacity. This extraordinary water absorption will ensure high reliability of accurate Covid-19 test results.

For additional information please contact us at info@mjbiotech.us.

Safe Harbor Statement: Some of the statements in this press release may be forward-looking statements or statements of future expectations based on currently available information. Such statements are naturally subject to risks and uncertainties. Factors such as the development of general economic conditions, future market conditions, unusual catastrophic loss events, changes in the capital markets and other circumstances may cause the actual events or results to be materially different from those anticipated by such statements. MJ Biotech Inc. does not make any representation or warranty, express or implied, as to the accuracy, completeness, or updated status of such statements. Therefore, in no case whatsoever will MJ Biotech. Inc. and its affiliate companies be liable to anyone for any decision made or action taken in conjunction with the information and/or statements in this press release or for any related damages.

SOURCE: MJ Biotech, Inc.

View source version on accesswire.com:
https://www.accesswire.com/631547/MJ-Biotech-Offers-Covid-19-FDA-Approved-Nasopharyngeal-Specimen-Collection-Swabs-RT-PCR-COVID-Test-Kit

FAQ

What new products has MJ Biotech added to its offering?

MJ Biotech has added FDA-approved nasopharyngeal specimen collection swabs for RT-PCR COVID tests.

How does the new RT-PCR COVID test benefit customers?

The RT-PCR COVID test allows customers to test for active COVID-19 infections, providing flexibility along with antibody tests.

Who is representing MJ Biotech in Africa?

Invest Africa Global, LLC is representing MJ Biotech in multiple jurisdictions across the African continent.

What is the significance of the FDA approval for the new product?

FDA approval of the nasopharyngeal swabs ensures product reliability and compliance with health regulations.

What steps is MJ Biotech taking for order fulfillment?

MJ Biotech is currently establishing logistics for order delivery and payment processes after the initial shipment.